Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 2320-2330

  Nyambi, Phillipe N ^a   Lewi, Paul ^b   Peeters, Martine ^d   Janssens, Wouter ^a   Heyndrickx, Leo ^a   Fransen, Katrien ^a   Andries, Koen ^b   Vanden Haesevelde, Marleen ^c   Heeney, Jonathan ^e   Piot, Peter ^f   Van Der Groen, Guido ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c INNOGENETICS   (Belgium)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^e BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^f UNAIDS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CHIMPANZEE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS NEUTRALIZATION;

EID: 0031048980     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.2320-2330.1997     Document Type: Article

References (58)

1. Allen, D. M. 1974. The relationship between variable selection and data augmentation and a method for prediction. Technometrics 16:125-127.
2. Andries, K., B. Dewindt, J. Snoeks, L. Wouters, H. Moereels, P. J. Lewi, and P. A. J. Janssen. 1990. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J. Virol. 64:1117-1123.
3. Arendrup, M., A. Sonnerborg, B. Svennerholm, L. Akerblom, C. Nielsen, H. Clansen, S. Olofsson, J. O. Nielsen, and J. E. Hansen. 1993. Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. J. Gen. Virol. 74:855-863.
4. Asjö, B., L. Mörfeldt-Manson, J. Albert, G. Biberfeld, A. Karlsson, K. Lidman, and E. M. Fenyö. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii:660-663.
5. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:496-503.
6. Bremermann, H. J. 1995. Mechanism of HIV presistence: implications for vaccines and therapy. J. Acquired Immune Defic. Syndr. 9:459-483.
7. Cheng-Meyer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
8. Daeyaert, F., H. Moereels, and P. J. Lewi. Classification and identification of proteins by means of common and specific amino acid n-tuples in unaligned sequences. Submitted for publication.
9. De Beenhouwer, H., H. Verhaert, H. Claeys, and C. Vermylen. 1992. Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction. Vox Sang. 63:198-203.
10. Delassus, S., R. Cheynier, and S. Wain-Hobson. 1991. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J. Virol. 65:225-231.
11. Earl, P. L., C. C. Broder, D. Long, S. A. Lee, J. Peterson, S. Chakrabarti, R. W. Doms, and B. Moss. 1994. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68:3015-3026.
12. Fenyö, E. M., J. Albert, and B. Asjö. 1989. Replicative capacity, cytopathic effect and cell tropism of HIV. AIDS 3(Suppl. 1):S5-S12.
13. Fenyö, E. M., L. Mörfeldt-Manson, F. Chiodi, B. Lind, A. von Gegerfelt, J. Albert, E. Olausson, and B. Asjo. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
14. Gorny, M. K., J. P. Moore, A. J. Conley, S. Karwowska, J. Sodroski, C. Williams, S. Burda, L. J. Boots, and S. Zolla-Pazner. 1994. Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. J. Virol. 68:8312-8320.
15. Goudsmit, J., K. Ljunggren, L. Smit, M. Jondal, and E. M. Fenyö. 1988. Biological significance of the antibody response to HIV antigens expressed on the cell surface. Arch. Virol. 103:189-206.
16. Haigwood, N., J. Shuster, G. Moore, H. Lee, P. V. Skiles, K. W. Higgins, P. J. Barr, C. George-Nascimento, and K. S. Steimer. 1990. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res. Hum. Retroviruses 6:855-869.
17. Ho, D. D., G. M. Sarngadharan, M. S. Hirsch, R. T. Schooley, T. R. Rota, R. C. Kennedy, T. C. Chanh, and V. L. Sato. 1987. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J. Virol. 61:2024-2028.
18. Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N. C. Sun, and J. Robinson. 1991. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
19. Holmes, E. C., L. Q. Zhang, P. Simmonds, C. A. Ludlam, and A. J. Leigh Brown. 1992. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc. Natl. Acad. Sci. USA 89:4835-4839.
20. Huet, T., R. Cheynier, A. Meyerhans, G. Roelants, and S. Wain-Hobson. 1990. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature 345:356-359.
21. Lamers, S. L., J. W. Sleasman, J. X. She, K. A. Barrie, S. M. Pomeroy, D. J. Barrett, and M. M. Goodenow. 1994. Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants infected by vertical transmission. J. Clin. Invest. 93:380-390.
22. Lamers, S. L., J. W. Sleasman, J. X. She, K. A. Barrie, S. M. Pomeroy, D. J. Barrett, and M. M. Goodenow. 1993. Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo. J. Virol. 67:3951-3960.
23. Lee, C.-N., J. Robinson, G. Mazzara, Y. L. Cheng, M. Essex, and T. H. Lee. 1995. Contribution of hypervariable domains to the conformation of a broadly neutralizing glycoprotein 120 epitope. AIDS Res. Human Retroviruses 11:777-781.
24. Lewi, P. J. 1995. Spectral mapping of drug-test specificities, p. 219-253. In H. van de Waterbeemd (ed.), Chemometrics in molecular design. VCH, Weinheim, Germany.
25. Lewi, P. J. 1982. Multivariate data analysis in industrial practice. Research Studies Press and John Wiley & Sons, Ltd., Chichester, England.
26. Lewi, P. J. 1989. Spectral map analysis. Analysis of contrasts especially from log ratios. Chemometrics Intelligent Lab. Syst. 5:105-116.
27. Lewi, P. J. 1996. Spectral mapping, a technique for classifying biological activity profiles of chemical compounds. Arzneim.-Forsch. 26:1295-1300.
28. Lewi, P. J. 1995. Spectral mapping of drug-test specificities. Doctoral thesis. Vrije Universiteit Brussel, Brussels, Belgium.
29. Lewi, P. J., H. Moereels, and D. Adriaensen. 1992. The combination of dendrograms with plots of latent variables. An application to G-proteins coupled receptor sequences. Chemometrics Intelligent Lab. Syst. 16:145-154.
30. Matsushita, S., M. Robert-Guroff, J. Rusche, A. Koito, T. Hattori, A. Hoshino, K. Javaherian, K. Takatsuki, and S. Putneys. 1988. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62:2107-2114.
31. McKeating, J. A., C. Shotton, J. Cordell, S. Graham, P. Balfe, N. Sullivan, M. Charles, M. Page, A. Bolmstedt, S. Olofsson, C. S. Kayman, Z. Wu, A. Pinter, C. Dean, J. Sodroski, and R. A. Weiss. 1993. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120. J. Virol. 67:4932-4944.
32. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, L. Morfelt-Manson, B. Asjo, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910.
33. Michael, L. N., E. K. Davis, D. L. Loomis-Price, C. T. Van Cott, S. D. Burke, R. R. Redfield, and L. D. Brix. 1996. V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1 infected patients. AIDS 10:121-129.
34. Moore, J. P., and D. D. Ho. 1992. Conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
35. Moore, J. P., H. Yoshiyama, D. D. Ho, J. E. Robinson, and J. Sodroski. 1993. Antigenic variation in gp120s from molecular clones of HIV-1 LAI. AIDS Res. Hum. Retroviruses 9:1185-1193.
36. Moore, J. P., Q. J. Sattentau, R. Wyatt, and J. Sodroski. 1994. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:469-484.
37. Nowak, M. A., and R. M. May. 1992. Coexistence and competition in HIV infections. J. Theor. Biol. 159:329-342.
38. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Köppe, K. Sigmund, C. R. M. Bangham, and E. J. McMichael. 1995. Antigenic oscillations and shifting immunodomi-nance in HIV-1 infections. Nature 375:606-611.
39. Nyambi, P. N., J. Nkengasong, M. Peeters, F. Simon, J. Eberle, W. Janssens, K. Fransen, B. Willems, K. Vereecken, L. Heyndrickx, P. Piot, and G. van der Groen. 1995. Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J. Infect. Dis. 172:1228-1237.
40. Nyambi, P. N., J. Nkengasong, P. Lewi, K. Andries, W. Janssens, K. Fransen, L. Heyndrickx, P. Piot, and G. van der Groen. 1996. Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J. Virol. 70:6235-6243.
41. Palker, T. J., M. E. Clark, A. Langlois, T. J. Matthews, K. J. Weinhold, R. R. Randall, D. P. Bologenesi, and B. F. Haynes. 1988. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85:1932-1936.
42. Pang, S., Y. Shlesinger, E. S. Daar, T. Moudgil, D. D. Ho, and I. S. Y. Chen. 1992. Rapid generation of sequence variation during primary HIV-1 infection. AIDS 6:453-460.
43. Pedroza Martins, L., N. Chenciner, and S. Wain-Hobson. 1992. Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp120 envelope sequence. Virology 191:837-845.
44. Peeters, M., K. Fransen, E. Delaporte, M. Vanden Haesevelde, G. M. Gershy-Damet, L. Kestens, G. van der Groen, and P. Piot. 1992. Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS 6:447-451.
45. Peeters, M., W. Janssens, M. Vanden Haesevelde, K. Fransen, B. Willems, L. Heyndrickx, L. Kestens, P. Piot, G. van der Groen, and J. Heeney. 1995. Virologie and serologic characteristics of a natural chimpanzee lentivirus infection. Virology 211:312-315.
46. Pollard, S. R., M. D. Rosa, and D. C. Wiley. 1992. Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO J. 11:585-591.
47. Rusche, J. A., K. Javaherian, C. McDanal, J. Petro, D. L. Lynn, R. Grimaila, A. Langlois, R. C. Gallo, L. O. Arthur, P. J. Fischinger, et al. 1988. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad. Sci. USA 85:3198-3202.
48. Schwartz, S., B. K. Felber, E. M. Fenyö, and G. N. Pavlakis. 1989. Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines. Proc. Natl. Acad. Sci. USA 86:7200-7203.
49. Simmonds, P., L. Q. Zhang, F. Mcomish, P. Balfe, C. A. Ludlam, and A. J. Leigh Brown. 1991. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. J. Virol. 65:6266-6276.
50. Sneath, P. H., and R. R. Sokal. 1973. Numerical taxonomy. W. H. Freeman & Co., San Francisco, Calif.
51. Stamatatos, L., and C. Cheng-Meyer. 1995. Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. J. Virol. 69:6191-6198.
52. Tersmette, M., R. A. Gruters, F. de-Wolf, R. E. Goede, J. M. Lang, P. T. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
53. Vanden Haesevelde, M., M. Peeters, G. Jannes, W. Janssens, G. van der Groen, P. M. Sharp, and E. Saman. 1996. Sequence analysis of a HIV-1 related lentivirus isolated from a wild captured chimpanzee. Virology 221:346-350.
54. Van Kerckhoven, I., K. Fransen, M. Peeters, H. De Beenhouwer, P. Piot, and G. van der Groen. 1994. Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. J. Clin. Microbiol. 32:1669-1673.
55. Wolfs, T. F., J. J. de Jong, H. Van den Berg, J. M. Tijnagel, W. J. Krone, and J. Goudsmit. 1990. Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. Proc. Natl. Acad. Sci. USA 87:9938-9942.
56. Wyatt, R., N. Sullivan, M. Thali, H. Repke, D. Ho, J. Robenson, M. Posner, and J. Sodroski. 1993. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67:4557-4565.
57. Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. Leigh Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
58. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179-1181.